| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 04/14/2011 | CA2776847A1 Pyrrolo [3,2 -e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | CA2776844A1 Pyrrolo [3, 2 -e] [1,2,4] triazolo [1,5 -a] pyrimidines derivatives as inhibitors of microglia activation |
| 04/14/2011 | CA2776690A1 Heterocyclic compounds useful as pdk1 inhibitors |
| 04/14/2011 | CA2774215A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists |
| 04/14/2011 | CA2774031A1 Automated radiosynthesis |
| 04/14/2011 | CA2773205A1 Phenylpyri(mi)dinylazoles |
| 04/13/2011 | EP2308960A1 Cell adhesion promoting agent and method of promoting cell adhesion |
| 04/13/2011 | EP2308879A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/13/2011 | EP2308876A1 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists |
| 04/13/2011 | EP2308870A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308867A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308866A1 Phenylpyri(mi)dinylpyrazoles and their use as fungicides |
| 04/13/2011 | EP2308843A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2308509A1 Inhibitor of analgesic tolerance |
| 04/13/2011 | EP2307419A2 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 04/13/2011 | EP2307418A1 Novel phenylimidazopyrazines |
| 04/13/2011 | EP2307417A2 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds |
| 04/13/2011 | EP2307416A2 Substituted tricyclic derivatives against neurodegenerative diseases |
| 04/13/2011 | EP2307413A1 Novel phenyl-imidazopyridines and pyridazines |
| 04/13/2011 | EP2307407A2 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 04/13/2011 | EP2307365A1 Synthesis and use of heterocyclic antibacterial agents |
| 04/13/2011 | EP2306985A2 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 04/13/2011 | EP2306836A1 Bmi-1 protein expression modulators |
| 04/13/2011 | EP1928886B1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 04/13/2011 | EP1745046B1 1 h-indazoles, benzothiazoles, 1,2-benziosoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 04/13/2011 | EP1539763B1 Azaindole kinase inhibitors |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1840531B Porphyrin-based compounds for tumor imaging and photodynamic therapy |
| 04/13/2011 | CN102017220A Compound for organic electric field light-emitting element and organic electric field light-emitting element |
| 04/13/2011 | CN102017218A Organic electroluminescent element |
| 04/13/2011 | CN102015721A Total synthesis of SALINOSPORAMIDE A and analogs thereof |
| 04/13/2011 | CN102015720A Selective ligands for the neuronal nicotinic receptors and uses thereof |
| 04/13/2011 | CN102015719A Pyrrolotriazine kinase inhibitors |
| 04/13/2011 | CN102015718A 1- (7-(hexahydropyrrolo [3, 4-C] pyrrol-2 (1H) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3) |
| 04/13/2011 | CN102015717A Chemokine receptor modulators |
| 04/13/2011 | CN102015716A Imidazo [1,2-b] pyridazine derivatives for the treatment of C-MET tyrosine kinase mediated disease |
| 04/13/2011 | CN102015715A Fused pyrimidineone compounds as TRPV3 modulators |
| 04/13/2011 | CN102015714A 1' -substituted CARBA-nucleoside analogs for antiviral treatment |
| 04/13/2011 | CN102015713A Inhibitors of protein kinases |
| 04/13/2011 | CN102015711A Spiro-indole derivatives for the treatment of parasitic diseases |
| 04/13/2011 | CN102015708A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| 04/13/2011 | CN102015706A Imidazolidinone derivatives as 11B-HSD1 inhibitors |
| 04/13/2011 | CN102015702A Cyclic ethers |
| 04/13/2011 | CN102015677A Pyrimidinone derivatives and methods of use thereof |
| 04/13/2011 | CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists |
| 04/13/2011 | CN102014914A 3H-[1,2,3]triazolo[4,5-D]pyrimidine compounds, their use as MTOR kinase and PI3 kinase inhibitors, and their syntheses |
| 04/13/2011 | CN102010415A Heterocyclic compound and organic luminescence display device including the same |
| 04/13/2011 | CN102010414A Heterocyclic compound and organic light-emitting device and panel display device including same |
| 04/13/2011 | CN102010410A Heterocyclic compound and organic light emitting device including same |
| 04/13/2011 | CN102010360A Benzo cyclic chiral diamine |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/12/2011 | US7923555 Fused bicyclic mTor inhibitors |
| 04/12/2011 | US7923465 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 04/12/2011 | US7923461 TNF-α production inhibitors |
| 04/12/2011 | CA2481480C Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2474875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2,-a]pyrimidin-5(1h)-one derivatives |
| 04/12/2011 | CA2446221C Stable powder inhalation dosage formulation |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/07/2011 | WO2011041747A2 Neutral mixed ligand transition metal complexes as active materials in solid-state organic photovoltaic devices |
| 04/07/2011 | WO2011041713A2 Piperazinyl antiviral agents |
| 04/07/2011 | WO2011041399A2 Pi3k (delta) selective inhibitors |
| 04/07/2011 | WO2011041304A2 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase |
| 04/07/2011 | WO2011041293A1 Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
| 04/07/2011 | WO2011040600A1 NOVEL ANTIBACTERIAL AGENT TARGETING RESPONSE REGULATOR WaIR(YycF) |
| 04/07/2011 | WO2011039459A2 Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | WO2010046215A3 Diaza-indole derivatives and their use as fungicides |
| 04/07/2011 | US20110082294 Novel bicyclic compounds |
| 04/07/2011 | US20110082293 Process for the preparation of sterile doripenem |
| 04/07/2011 | US20110082292 High-purity large-scale preparation of stannsoporfin |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082159 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/07/2011 | US20110082158 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/07/2011 | US20110082147 Substituted imidazotriazines |
| 04/07/2011 | US20110082137 New compounds for the treatment of cns disorders |
| 04/07/2011 | US20110082136 Inhibitors of janus kinases |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110082111 Polo-like kinase inhibitors |
| 04/07/2011 | US20110081315 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/07/2011 | CA2775942A1 Pi3k (delta) selective inhibitors |
| 04/07/2011 | CA2775354A1 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase |
| 04/06/2011 | EP2305682A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/06/2011 | EP2305681A1 Crystalline form of pemetrexed diacid and process for the preparation thereof |
| 04/06/2011 | EP2305664A1 Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
| 04/06/2011 | EP2305647A1 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| 04/06/2011 | EP2303891A1 Pyrazolo-quinazolines |
| 04/06/2011 | EP2303890A2 Phosphatidylinositol 3 kinase inhibitors |
| 04/06/2011 | EP2303889A1 Halo-substituted pyrimidodiazepines as plkl inhibitors |
| 04/06/2011 | EP2303888A2 Methods and compounds for antimicrobial intervention |
| 04/06/2011 | EP2303887A1 Alpha helix mimetics and methods relating thereto |
| 04/06/2011 | EP2303886A2 Pi3k/m tor inhibitors |
| 04/06/2011 | EP2303885A1 Process for producing bicycloaniline derivatives |
| 04/06/2011 | EP2303881A2 Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| 04/06/2011 | EP2303880A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/06/2011 | EP2303878A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 04/06/2011 | EP2303876A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| 04/06/2011 | EP2303841A1 Oxindolyl inhibitor compounds |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |